drugset / Trial / NCT05146999
Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines
RandomizedParallel-groupTriple-blindTreatment
Summary
The objective of this study is to evaluate the aesthetic improvement and onset of QM1114-DP treatment for subjects with moderate to severe glabellar lines
Timeline
- Start
- 2022-05-09
- Primary completion
- 2022-10-28
- Completion
- 2023-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin | Protein / enzyme biologic | — | — |
Indications
No indication recorded.